Literature DB >> 28260993

Clinical application of a novel endoscopic mask: A randomized controlled trial in aged patients undergoing painless gastroscopy.

Guangyu Cai1, Zhenling Huang2, Tianxiao Zou1, Miao He1, Shanjuan Wang2, Ping Huang2, Bin Yu1.   

Abstract

Background: Desaturation during painless gastroscopy in aged patients leads to discontinuation of the procedure, prolonged manipulation time and increased risk of severe complications. An endoscopic nasal mask was designed to control hypoxia during the above procedures. A randomized trial was performed to test whether the novel endoscopic mask is helpful for hypoxia during painless gastroscopy in aged patients.
Methods: In this randomized, controlled trial, 141 aged patients undergoing painless gastroscopy were randomized into nasal catheter group (69 patients) and endoscopic mask group (65 patients). Primary outcomes were minimum pulse oxygen saturation and incidence of pulse oxygen saturation ≤ 90%.
Results: Finally, 134 aged patients were analyzed, including 69 patients in nasal catheter group and 65 patients endoscopic mask group. The minimum pulse oxygen saturation (96.4% ± 4.8%) was higher in the aged endoscopic mask group than in the aged nasal catheter group (94.3% ± 5.6%, P = 0.0075). The incidence of pulse oxygen saturation ≤ 90% did not significantly differ between the endoscopic mask group and nasal catheter group (6.2% VS 15.9%, P = 0.07). There were no severe adverse events in either groups.
Conclusion: The endoscopic mask was safely used in aged patients during painless gastroscopy under propofol sedation and significantly improved the minimum pulse oxygen saturation without increasing time to examination or recovery time.

Entities:  

Keywords:  aged; gastroscopy; mask; propofol.

Mesh:

Substances:

Year:  2017        PMID: 28260993      PMCID: PMC5332846          DOI: 10.7150/ijms.16919

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


Introduction

Propofol, a short-acting intravenous anaesthetic, is widely used in painless gastroscopy because it is associated with rapid effects and rapid recovery from anesthesia1. However, owing to individual differences in the tolerance to anaesthetics, some patients may display a lower depth of anesthesia or delayed recovery from anesthesia after gastrointestinal endoscopic examination. Furthermore, propofol occasionally causes respiratory depression, resulting in hypoxia, decreasing of SPO2 and discontinuation of the procedure1, 2. Tongue retraction after propofol-induced anesthesia can result in respiratory depression and respiratory tract obstruction, and decrease pulse oxygen saturation3, 4. In particular, aged patients with cardiovascular diseases or decreased cardiopulmonary functional reserve are prone to developing severe complications because of anesthesia-induced hypoxia5, 6. In this study, a novel multifunctional endoscopic mask was designed to provide oxygen and prevent hypoxia during painless gastroscopy (Fig. 1 and Fig. 2). We estimated the effects of this mask on minimum pulse oxygen saturation, incidence of adverse reactions, number of intubation attempts, time to intubation or examination, recovery time and propofol dosage in patients undergoing painless gastroscopy.
Figure 1

The endoscopic mask used in this study.

Figure 2

Pictorial depiction of the mask: (1) respiratory interface, (2) bellows, (3) nasal opening, (4) oral opening, (5) gasbag, (6) oropharyngeal airway and (7) one-way valve.

Material and methods

This randomized, controlled, single-blind trial was approved by the ethics committee of Shanghai Tongji Hospital (no. 199), and registered in the Chinese Clinical Trial Registry (http://www.chictr.org.cn; registration no.: ChiCTR-TRC-13004086; principal investigator: Bin Yu; date of registration:8th, Sep, 2013). The subjects were patients who underwent painless gastroscopy on an outpatient basis in Shanghai Tongji Hospital and Shanghai Renji Hospital. All subjects provided written informed consent before participating in the study. Eligible subjects aged 65-80 years with a body mass index of ≤25had American Society Anesthesiologists physical status scores of I or II, with no serious cardiopulmonary or kidney diseases. Exclusion criteria are: 1) Serious coronary heart disease and myocardial injury with serious heart failure; 2) Stenosis of the esophagus or cardia obstruction; 3) Aortic aneurysm; 4) Hemorrhagic shock; 5) Acute pharyngitis and tonsillitis; 6) Pneumonia or other infectious fever; 7) Asthmatic breathing difficulties; 8) Severe pulmonary dysfunction; 9) Physical extreme weakness; 10) Patients did not cooperate or spirit was not normal; 11) Acute upper gastrointestinal bleeding; 12) Allergic to propofol or the emulsifier content; 13) Pregnancy and lactation women; 14) Severe sleep apnea syndrome. All experiments were conducted in gastroscope room with a standard anesthesia workstation. An experienced anesthetist cared for the subjects and managed any emergency situations with professional resuscitation equipment. The gastroscope was passed into the esophagus or stomach via the oral opening of the endoscopic mask (PRC patent, ZL2012 1 0286504.5). During the procedure, the oxygen-flow rate was set at 5 L/min. The respiratory interface, which was connected to the oxygen supply equipment, was used for first-aid measures if hypoxia occurred. The study was a randomized, controlled, single blind trial(patient-blinded), and subjects aged 65-80 years were randomized into nasal catheter group and endoscopic mask group. Eligible subjects scheduled to undergo painless gastroscopy were fasted for 12 h before the start of the examination, and their essential information was recorded, including sex, age, weight, height and important history. Basal pulse oxygen saturation was observed, and unilateral intravenous access via a peripheral vein in an upper limb was established for the injection of propofol and any salvage drugs. Electrocardiographic data, pulse oxygen saturation, respiration, heart rate and blood pressure were monitored during the procedure. The nasal catheter or endoscopic mask was placed before the administration of propofol and the oxygen-flow rate in both groups was 5 L.min-1. Subjects were placed in the left lateral recumbent position and instructed to breathe deeply. A 1 mg.kg-1 propofol dose was injected intravenously within 50 s in the nasal catheter groups and endoscopic mask groups, with all subjects maintaining spontaneous respiration. Gastroscopy was performed after the palpebral reflex had disappeared, and an additional 30-50 mg dose of propofol was injected during the operation. If the pulse oxygen saturation decreased to ≤90% during the procedure, the mandible was lifted to relieve airway obstruction; if the pulse oxygen saturation decreased to ≤85%, pressurized oxygen was supplied to guarantee the safety of the subjects. Subjects were sent to the post-anesthesia care unit (PACU) for observation for 20 min after painless gastroscopy and were followed up 1 h later. The primary outcomes were minimum pulse oxygen saturation and incidence of pulse oxygen saturation ≤ 90%. The secondary outcomes included the incidence of adverse reactions, time to examination, recovery time and propofol dosage (including basal dose and additional dose). The adverse reactions included arrhythmia, tongue retraction, cough, agitation, hiccups, reflux and aspiration. Recovery time was measured using the Observer's Assessment of Alertness/Sedation scale (OAAS, Table 1) 7, 8. An OAAS score of 5 indicated rapid response to normal voice. The recovery time was calculated from the beginning of the procedure to the acquisition of an OAAS score of 5 in the PACU.
Table 1

Observer's Assessment of Alertness/Sedation Scale.

1Does not respond to mild prodding or shaking
2Responds to mild prodding or shaking
3Responds only after name is spoken loudly or repeatedly
4Lethargic response to name spoken in normal tone
5Responds readily to name spoken in normal tone

Statistical analysis

Continuous variables were compared using the t-test or Mann-Whitney U test, depending on the distribution of the data. Categorical variables were compared using the Pearson chi-square test or Fisher exact test. Statistical significance was assumed at a two-sided P value of <0.05. The results were expressed as means with SDs. The statistical analyses were performed using SPSS version 20.0 (SPSS Inc., Chicago, IL).

Results

A total of 141 patients met the inclusion criteria for painless gastroscopy, and agreed to participate in the study (Fig. 3). 7 patients were lost to follow-up. Finally, 134 aged patients were analyzed, including 69 in nasal catheter group and 65 in the endoscopic mask group. The baseline characteristics of the aged patients were balanced between the endoscopic mask and nasal catheter groups (Table 2).
Figure 3

Flow chart of participant selection for painless gastroscopy.

Table 2

Demographic and clinical characteristics of aged patients who underwent painless gastroscopy

Endoscopic mask group (n=65)Nasal catheter group (n=69)
Age, yr (SD)70.6(5.6)70.1(4.4)
Male (%)32(49.2)28(40.6)
Weight, kg (SD)58.2(11.5)59.9(10.1)
Hypertension (%)13(20)17(24.6)
Diabetes (%)4(6.2)6(8.7)
Arterial coronary disease (%)6(9.2)6(8.7)
Cerebrovascular disease (%)1(1.5)2(2.9)
Atrial septal defect (%)01(1.4)
Atrial fibrillation (%)3(4.6)1(1.4)
Liver cirrhosis (%)1(1.5)1(1.4)
Chronic obstructive pulmonary disease (%)1(1.5)1(1.4)
Renal insufficiency (%)3(4.6)0
Parkinson disease (%)1(1.5)0
Asthma (%)1(1.5)0
ASA risk score (%)
I33(50.8)36(52.2)
II32(49.2)33(47.8)
Basal SPO2, %(SD)96.4(2.7)97.0(2.0)

Note: SPO2, pulse oxygen saturation; ASA, American Society of Anesthesiologists.

The minimum pulse oxygen saturation during painless gastroscopy was significantly higher in endoscopic mask group (96.4% ± 4.8%) than in nasal catheter group (94.3% ± 5.6%, P = 0.0075; Fig. 4). The incidence of pulse oxygen saturation ≤ 90% did not significantly differ between the endoscopic mask group (6.2%, 4/65) and nasal catheter group (15.9%, 11/69), P = 0.07; Fig. 5)
Figure 4

Minimum pulse oxygen saturation (SPO2) during painless gastroscopy in aged patients. The minimum SPO2 was higher in the endoscopic mask group than in the nasal catheter group among aged patients (*P = 0.0075).

Figure 5

The incidence of SPO2 ≤ 90% during painless gastroscopy in the mask group and catheter group of aged patients.

The results demonstrated the use of endoscopic mask had no significant differences in time to examination (P = 0.70), recovery time (P = 0.66) and propofol dosage (P = 0.35) between the endoscopic mask group and nasal catheter group (Table 3). Similarly, incidence of cough, agitation, hiccups or arrhythmia between endoscopic mask group and nasal catheter group showed no differences (all P > 0.05, Table 3).
Table 3

Secondary outcomes in aged patients who underwent painless gastroscopy

Endoscopic mask group(n=65)Nasal catheter group(n=69)P Value
Time consuming, s(SD)280.9(131.6)272.0(132.1)0.70
Recovery time, s(SD)581.3(258.8)600.8(248.1)0.66
Propofol dosage, mg(SD)100.3(27.6)104.9(28.6)0.35
Adverse reactions
Cough (%)12(18.5%)21(30.4%)0.11
Agitation (%)1(1.5%)00.49
Hiccup (%)01(1.4%)1
Arrhythmia (%)02(2.9%)0.53

Discussion

The use of the endoscopic mask in aged patients during painless gastroscopy increased the minimum pulse oxygen saturation without increasing the time to examination. Several factors are considered to contribute to hypoxia during gastroscopy. The insertion of the endoscopic probe into the esophagus and stomach through the oropharynx may produce mechanical obstruction of the pharynx or compress the trachea, leading to hypoxia3. The use of a sedative is another important cause of oxygen desaturation. General anesthesia is likely to cause respiratory center depression and lead to hypoventilation and hypoxemia, especially when several drugs are used together3, 9. Gradual anesthesia induction with propofol shows a linear relationship with the augmentation of upper airway collapsibility, which can cause airway obstruction4, 10. Patients with cardiopulmonary diseases are more sensitive to oxygen deficiency 5. Yazawa et al. studied 53 patients undergoing upper gastrointestinal endoscopy before cardiac surgery 6, aiming to determine the effects and risks of upper gastrointestinal procedures in patients with heart disease. Their results showed a higher incidence of oxygen desaturation in patients with a high New York Heart Association functional class. Oxygen requirements are high in aged patients because of age-related deterioration in cardiopulmonary function. The endoscopic mask provided a new method of controlling hypoxia during painless gastroscopy. Since gastroscopy is an invasive procedure and an unpleasant experience for patients, it is increasingly being performed under sedation, and propofol is commonly used to provide sedation during gastroscopy because it is short-acting and associated with rapid recovery, leading to high patient satisfaction11, 12. However, oxygen desaturation and cardiac side events can occur with the use of propofol sedation during esophagogastroduodenoscopy (EGD)1, 2. For the sake of safety, a pulse oxygen saturation of 90% or less during gastroscopy is considered to indicate hypoxia and require airway intervention to improve oxygen supply and prevent respiratory depression13, 14. During painless gastroscopy, continuous oxygen supply and pulse oximetry are recommended for reducing the incidence of oxygen desaturation, and for the monitoring and timely detection of hypoxia, respectively15. However, the incidence of propofol-related hypoxia has been reported to be highly variable (4%-50%) in the clinical practice guidelines of the Spanish Society of Digestive Endoscopy15. Compared to the routine mask, the endoscopic mask has several modifications (Fig. 1A). The endoscopic mask has a respiratory interface, an oral opening and a nasal opening in its surface. The respiratory interface is at the margin of the endoscopic mask, whereas it occupies a central position in routine masks. The oral opening is designed for gastroscope, oral tracheoscope, choledochoscope and enteroscope insertion, and the nasal opening serves as the passageway for nasal fiberoptic bronchoscopy or nasal tracheoscopy. The respiratory interface can connect to ventilation devices, and both the oral and nasal openings have valves to prevent air leakage. The endoscopic mask seals the face and can increase the fractional inspired oxygen. At the beginning of painless gastroscopy, adequate oxygen is provided through the respiratory interface. If oxygen desaturation occurs during painless gastroscopy, the respiratory interface can be connected to ventilation devices to enable safe continuation of the procedure without removing the endoscope. A nasal cannula and mouth opener with oxygen tubing are usually used to meet oxygen requirements during gastroscopy15. Ventilation using conventional interfaces is a real problem during gastroscopy, since it cannot be realized without removing the endoscope16, 17. When severe desaturation occurs (pulse oxygen saturation ≤ 85%), the endoscopic probe is removed to supply pressurized oxygen via a routine oxygen mask, interrupting the gastroscopy and causing inconvenience to the endoscopists and patients. The use of routine endoscopic masks can overcome this problem, as adequate oxygen supply can be delivered through the mask without removing the endoscope. However, a high-arched palate of routine endoscopic masks is not convenient for the insertion of an endoscopic probe, and routine endoscopic masks lack a nasal opening and a connector to the oropharyngeal airway. Our study showed that the use of the novel endoscopic mask in aged patients during painless gastroscopy increased the minimum pulse oxygen saturation without increasing the time to examination and recovery time. We did not conduct the study on patients older than 80 years for ethical reasons. However, the endoscopic mask has been used in several patients older than 80 years who had various complications in the clinic, with high patient and clinician satisfaction. We will design another study to estimate the effects of the endoscopic mask on patients older than 80 years with severe cardiopulmonary diseases. The novel endoscopic mask was primarily designed to supply oxygen during painless gastroscopy, awake nasal or oral fiberoptic bronchoscopic tracheal intubation, awake nasal or oral tracheoscopy, choledochoscopy and enteroscopy. The oropharyngeal airway connecting to the endoscopic mask is a unique point and combined use with the endoscopic mask could prevent respiratory depression caused by tongue retraction, thus the endoscopic mask can be applied to patients undergoing short surgeries under general anesthesia without the use of tracheal intubation or a laryngeal mask airway or neuromuscular blocking drugs, as well as for coma patients in the NICU(Nervous System Intensive Care Unit) after being fitted with an oropharyngeal airway. However, we did not design different sizes of mask based on our novel mask fitting for demand of endoscopy in infants and young children, and we will try to improve in this area.

Conclusions

The results of this study demonstrate that the use of the endoscopic mask increased minimum pulse oxygen saturation in the aged without severe adverse events or increasing the time to examination. We recommend its routine use during painless gastroscopy in aged patients, especially, in patients with complications or difficult airways.
  17 in total

1.  Propofol use during gastrointestinal endoscopy.

Authors:  D B Nelson; A N Barkun; K P Block; J S Burdick; G G Ginsberg; D A Greenwald; P B Kelsey; N L Nakao; A Slivka; P Smith; N Vakil
Journal:  Gastrointest Endosc       Date:  2001-06       Impact factor: 9.427

Review 2.  Recent advances in interfaces for non-invasive ventilation: from bench studies to practical issues.

Authors:  G F Sferrazza Papa; F Di Marco; E Akoumianaki; L Brochard
Journal:  Minerva Anestesiol       Date:  2012-10       Impact factor: 3.051

Review 3.  Interfaces for noninvasive mechanical ventilation: technical aspects and efficiency.

Authors:  L Pisani; A Carlucci; S Nava
Journal:  Minerva Anestesiol       Date:  2012-10       Impact factor: 3.051

4.  Sedation for gastrointestinal endoscopy.

Authors:  F Igea; J A Casellas; F González-Huix; C Gómez-Oliva; J S Baudet; G Cacho; M A Simón; E De la Morena; A Lucendo; F Vida
Journal:  Endoscopy       Date:  2014-07-25       Impact factor: 10.093

5.  Non-anaesthesiologists should not be allowed to administer propofol for procedural sedation: a Consensus Statement of 21 European National Societies of Anaesthesia.

Authors:  Azriel Perel
Journal:  Eur J Anaesthesiol       Date:  2011-08       Impact factor: 4.330

6.  Examination of cardiorespiratory changes during upper gastrointestinal endoscopy. Comparison of monitoring of arterial oxygen saturation, arterial pressure and the electrocardiogram.

Authors:  A W Murray; C G Morran; G N Kenny; P Macfarlane; J R Anderson
Journal:  Anaesthesia       Date:  1991-03       Impact factor: 6.955

7.  Patient-maintained propofol sedation using reaction time monitoring: a volunteer safety study.

Authors:  S Allam; K J Anderson; C O'Brien; J A Macpherson; S Gambhir; J A Leitch; G N C Kenny
Journal:  Anaesthesia       Date:  2012-11-15       Impact factor: 6.955

8.  Mechanisms of hypoxemia during panendoscopy.

Authors:  K P Rimmer; K Graham; W A Whitelaw; S K Field
Journal:  J Clin Gastroenterol       Date:  1989-02       Impact factor: 3.062

9.  Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy.

Authors:  J B Arrowsmith; B B Gerstman; D E Fleischer; S B Benjamin
Journal:  Gastrointest Endosc       Date:  1991 Jul-Aug       Impact factor: 9.427

10.  Adequate sedation with single-dose dexmedetomidine in patients undergoing transurethral resection of the prostate with spinal anaesthesia: a dose-response study by age group.

Authors:  Jeongmin Kim; Won Oak Kim; Hye-Bin Kim; Hae Keum Kil
Journal:  BMC Anesthesiol       Date:  2015-01-27       Impact factor: 2.217

View more
  6 in total

1.  LMA® Gastro™ Airway for endoscopic retrograde cholangiopancreatography: a retrospective observational analysis.

Authors:  Andre Tran; Venkatesan Thiruvenkatarajan; Medhat Wahba; John Currie; Anand Rajbhoj; Roelof van Wijk; Edward Teo; Mark Lorenzetti; Guy Ludbrook
Journal:  BMC Anesthesiol       Date:  2020-05-13       Impact factor: 2.217

2.  High-flow nasal oxygenation versus standard oxygenation for gastrointestinal endoscopy with sedation. The prospective multicentre randomised controlled ODEPHI study protocol.

Authors:  Axelle Eugene; Lucie Fromont; Adrien Auvet; Olivier Baert; Willy-Serge Mfam; Francis Remerand; Thierry Boulain; Mai-Anh Nay
Journal:  BMJ Open       Date:  2020-02-18       Impact factor: 2.692

3.  Comparison of the innovative endoscopic oropharyngeal airway and the conventional mouthpiece in elderly outpatients undergoing esophagogastroduodenoscopy under sedation: a prospective and randomized study.

Authors:  Wei Zhang; Chun Zhu; Xu Chen; Lei Tao; Keqiang He; Hao Wu; Xiaoqing Chai; Sheng Wang; Min Xia
Journal:  BMC Gastroenterol       Date:  2022-01-06       Impact factor: 3.067

4.  Intravenous Lidocaine Significantly Reduces the Propofol Dose in Elderly Patients Undergoing Gastroscopy: A Randomized Controlled Trial.

Authors:  Song Hu; Mingxia Wang; Siyu Li; Wenyu Zhou; Yi Zhang; Haobing Shi; Pengcheng Ye; Jixiong Sun; Feng Liu; Wei Zhang; Li Zheng; Qianhao Hou; Yue Wang; Weixin Sun; Yuanli Chen; Zhenzhen Lu; Zhonghua Ji; Lijun Liao; Xin Lv; Yinglin Wang; Xiangrui Wang; Hao Yang
Journal:  Drug Des Devel Ther       Date:  2022-08-12       Impact factor: 4.319

5.  High-flow nasal oxygen reduces the incidence of hypoxia in sedated hysteroscopy for assisted reproduction.

Authors:  Ying Tang; Ping Huang; Di Chai; Xiao Zhang; Xiaoyi Zhang; Shaoyi Chen; Diansan Su; Yonglei Huang
Journal:  Front Med (Lausanne)       Date:  2022-08-08

6.  Comparison of a Nasal Mask and Traditional Nasal Cannula During Intravenous Anesthesia for Gastroscopy Procedures: A Randomized Controlled Trial.

Authors:  Dong Xu Chen; Hui Yang; Xi Ping Wu; Wang Niu; Lin Ding; Huo Lin Zeng; Qian Li
Journal:  Anesth Analg       Date:  2022-03-01       Impact factor: 5.108

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.